GEME yields 6.48% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 4
Combined, GEME + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GEME + MRK for your $10,000?
GEME targets the growth potential of emerging markets via a concentrated portfolio of 20-50 equity and equity-related securities. Investments include common stock, preferred stock, and ADRs from large- and mid-cap companies. The fund allocates a minimum of 40% of its assets across multiple non-US countries and 30% during unfavorable conditions. The selection process follows a value-driven approach, seeking undervalued companies trading below intrinsic value, using proprietary valuation models that combine top-down macroeconomic analysis with bottom-up company research. Holdings may include fixed-income securities, participatory notes for restricted markets, and China A-shares, capped at 10%. Additionally, it uses derivatives for currency hedging and may employ up to 15% leverage for long positions, with short positions at 20% strictly reserved for hedging. Positions are sold when they exceed intrinsic value, show deteriorating fundamentals, or increase portfolio risk.
Full GEME Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.